| Financial Year |
March 31 2023 |
| Monetary Funds |
521,889,162.65 |
| Held-for-trading Financial Assets |
30,288,984.26 |
| Notes Receivable |
27,056,073.82 |
| Accounts Receivable |
656,698,379.83 |
| Advances to Suppliers |
14,573,819.83 |
| Other Receivables |
12,616,057.89 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,244,382,440.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
146,132,215.09 |
| Total Current Assets |
2,657,399,134.31 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
198,900,234.58 |
| Under-construction Projects |
178,527,790.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
52,563,562.83 |
| R&D expenses |
-- |
| Goodwill |
13,401,556.26 |
| Long-Term Deferred and Prepaid Expenses |
19,390.68 |
| Deferred Income Tax Assets |
19,090,510.29 |
| Other Non-Current Assets |
2,921,783.86 |
| Sub-Total of Non-Current Assets |
514,317,393.97 |
| Total Assets |
3,171,716,528.28 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
192,746,411.32 |
| Accounts Payable |
589,667,685.62 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
49,312,585.39 |
| Taxes Payable |
22,916,215.36 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
28,340,214.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
705,468.79 |
| Other Current Liabilities |
1,400,037.91 |
| Sub-Total of Current Liabilities |
895,858,141.51 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,405,529.88 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,483,047.98 |
| Total Liabilities |
901,341,189.49 |
| Paid-In Capital(Or Share Stock) |
272,566,880.00 |
| Capital Surplus |
830,817,049.62 |
| Surplus Reserve |
134,212,621.07 |
| LESS:Treasury Stock |
21,139,356.00 |
| Undistributed Profits |
1,031,200,013.22 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,270,375,338.79 |
| Owner's Equity（Stockholder's Equity） |
2,270,375,338.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,171,716,528.28 |
